C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2004
12/29/2004	EP1491540A1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1491533A2 Quinoline-and naphthalenecarboxamides, pharmaceutical compositions thereof and their use as calpain inhibitors
12/29/2004	EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors
12/29/2004	EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage
12/29/2004	EP1490349A1 Therapeutic ion channel blocking agents and methods of use thereof
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490341A1 Novel adamantane derivatives
12/29/2004	EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004	EP1490334A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004	EP1233769A4 Novel compounds
12/29/2004	EP1230224B1 Substituted 5-benzyl-2,4-diaminopyrimidines
12/29/2004	EP1226138B1 Fab i inhibitors
12/29/2004	EP1226136B1 Tyrosine kinase inhibitors
12/29/2004	EP1177178B1 Heterocyclically substituted benzimidazoles, the production and application thereof
12/29/2004	EP1176140B1 Amide compounds and medicinal use thereof
12/29/2004	EP1056729B1 N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia
12/29/2004	EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/29/2004	EP0934303B1 Compounds useful for inhibition of farnesyl protein transferase
12/29/2004	CN1558898A Antiviral agent
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1558764A Substituted urea neuropeptide Y Y5 receptor antagonists
12/29/2004	CN1558761A Substituted benzimidazole compounds and their use for the treatment of cancer
12/29/2004	CN1558759A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/29/2004	CN1558758A Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
12/29/2004	CN1558719A Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides
12/29/2004	CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
12/29/2004	CN1182114C Piperazine derivatives used as CCR5 antagonist
12/29/2004	CA2530461A1 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors
12/29/2004	CA2529161A1 Quinolyl amide derivatives as ccr-5 antagonists
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2526103A1 Cannabinoid derivatives, methods of making, and use thereof
12/29/2004	CA2525713A1 Benzofuran inhibitors of factor viia
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/28/2004	US6835845 Methine compound, material for organic luminescence element, and organic luminescence element using the same
12/28/2004	US6835844 Acrylic esters and use thereof
12/28/2004	US6835744 3,3-substituted indoline derivatives
12/28/2004	US6835739 Benzamides and related inhibitors of factor Xa
12/28/2004	US6835513 An organophotoreceptor comprising: (a) a charge transport compound having the formula carbazole compound dispersion of colorant particles in an organic liquid and charge transport compound having the formula of carbazole compound
12/28/2004	US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
12/28/2004	US6835474 Red fluorescent dyes having high fluorescent strength and high color purity; high luminance; high efficacy by low voltage-driving; stability; durability; color conversion filter, pulp dyeing; photographic dye; sensitizers
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/23/2004	WO2004111045A1 Pyrrolidine - 2- ones as factor xa inhibitors
12/23/2004	WO2004111032A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/23/2004	WO2004111014A1 Pyrimidine derivatives as modulators of atp-binding cassette transporters
12/23/2004	WO2004111013A1 Hepatitis c virus inhibitors
12/23/2004	WO2004110997A1 3- sulfonylamino- pyrrolidine- 2- one derivatives as inhibitors of factor xa
12/23/2004	WO2004110989A1 N-hydroxy-7-(arylamino)heptanamide derivatives useful for treating hyper-proliferative disorders
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110442A1 Pyridine n-oxides as antiviral agents
12/23/2004	WO2004110435A1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
12/23/2004	WO2004110434A1 2-pyrrolidone derivatives and use thereof as factor xa inhibitors
12/23/2004	WO2004091518A3 Cxcr4 chemokine receptor binding compounds
12/23/2004	WO2004089908A3 3-azabicyclo[3.2.1]octane derivatives
12/23/2004	WO2004087048A3 Benzamide modulators of metabotropic glutamate receptors
12/23/2004	WO2004085409A3 Compounds and libraries of pyridines, pyrazines, imidazo[1,2-a]pyrazines and 1h-imidazo[4,5-b]pyrazin-2-ones and first and second medical uses thereof
12/23/2004	WO2004085392A8 Melatonin derivatives and their use for treating neurological dysfunctions
12/23/2004	WO2004074270A3 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
12/23/2004	WO2004072025A3 Substituted n-arylheterocycles, method for production and use thereof as medicaments
12/23/2004	WO2004071390A3 Piperazine-2-carboxamide derivatives
12/23/2004	WO2004055010A3 Cyclopropyl compounds as ccr5 antagonists
12/23/2004	WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators
12/23/2004	US20040260094 such as 8-amino-4-benzylamino-quinoline-3-carboxylic acid ethyl ester; for treatment of Alzheimer's disease, Huntington's disease, Parkinson's disease, AIDS, stroke, ischemia, traumatic brain injury, spinal cord injury or osteoarthritis
12/23/2004	US20040259931 An urea derivative containing amide, amine or substitued amine groups and pyrrolidine ring(s), useful for treating obesity, anxiety or depression
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259926 carbocyclic sulfides such as {4-[5-Methoxy-6-methyl-2-(2H-tetrazol-5-ylcarbamoyl)-benzo[b]thiophene-3-yloxy]-phenyl}-acetic acid ethyl ester, used as phosphatidyl inositol 3-kinase inhibitors; antiinflammatory and anticarcinogenic agents; prophylaxis of cardiovascular disorders
12/23/2004	US20040259921 EP4 receptor selective agonists in the treatment of osteoporosis
12/23/2004	US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid
12/23/2004	US20040259904 for treating cancer; 4'-(6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-yl)-1,1'-biphenyl-4-yl 1,4'-bipiperidine-1'-carboxylate for example
12/23/2004	US20040259884 Antiproliferative agents; antitumor agents; using 1-(4,5-bis(4-chlorophenyl)-2-(2,4-dimethoxyphenyl)-4,5-imidazol-1-yl)-2-methylpropan-1-one
12/23/2004	US20040259868 Serine protease inhibitors
12/23/2004	US20040259860 Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
12/23/2004	US20040259859 Therapy for diseases caused by opioid receptors; irratible bowel disorders; drug abuse; antidepressants; anxiolytic agents; schizophrenia; eating disorders
12/23/2004	US20040259031 Specific dye compound, optical information recording medium comprising specific dye, and information recording method using this optical information recording medium
12/23/2004	US20040255397 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratimous fibers
12/23/2004	DE10325962A1 Aroylsemicarbazidderivate Aroylsemicarbazidderivate
12/23/2004	DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds
12/23/2004	DE102004023605A1 New (pyrazol-4-yl)-(2,3-dihydro-benzofuran-4-yl or -benzothiophen-4-yl)-methanone derivatives, useful as pre- or post-emergence, total or selective herbicides or plant growth inhibitors
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2527851A1 Hepatitis c virus inhibitors
12/23/2004	CA2527586A1 Pyridine n-oxides as antiviral agents
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2525207A1 Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
12/22/2004	EP1489418A1 Novel fluorescent label compounds
12/22/2004	EP1489077A1 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487826A1 New crystalline forms of (2s)-n-5- amino(imino)methyl -thienylmethyl-1-(2r)-2- (carboxymethyl)amino -3,3-diphenylpropanoyl-2-pyrrolidinecarboxamide nh2o
12/22/2004	EP1487824A1 Diamino-pyrimidines and their use as angiogenesis inhibitors
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487813A1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487803A1 Indazoles substituted with an anti-cancerous activity
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487797A1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
12/22/2004	EP1487794A1 Monocyclic aroylpyridinones as antiinflammatory agents

1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 523